Today: 30 June 2026
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

New York, Jan 5, 2026, 14:02 EST — Regular session

  • D-Wave Quantum shares rose nearly 10% on Monday afternoon, trading around $30.91.
  • An options-market scan flagged a burst of unusually large trades, mostly calls, according to Benzinga.
  • Investors are looking to D-Wave’s CES Foundry appearance on Jan. 7–8 for signs of new customers or partners.

Shares of D-Wave Quantum Inc. (QBTS) rose nearly 10% on Monday, lifting the quantum-computing stock back toward $31 as traders tracked an uptick in options activity ahead of this week’s CES events.

The rally matters because QBTS has become a bellwether for risk appetite in the thinly traded “quantum” corner of the market, where sentiment can turn on conference demos and headlines more quickly than on quarterly fundamentals.

With CES days away, investors are watching for any customer wins, partnerships or product-readout details that can be tied to revenue, not just demonstrations. A muted update can also trigger a fast “sell-the-news” reversal after a sharp run.

Benzinga said its options scanner flagged 12 unusually large options trades in QBTS on Monday, with 10 call trades totaling about $587,000 and two put trades worth about $72,000. Calls are contracts that profit from a rise in the stock price, while puts are often used to bet on or protect against declines.

D-Wave said in a Dec. 22 release that it will sponsor the CES Foundry event in Las Vegas on Jan. 7–8, and that Murray Thom will lead a masterclass and demo on Jan. 7. “Showcasing quantum computing at CES, one of the world’s most influential technology stages, signals that the technology is quickly moving into the mainstream,” Thom said. Company release

Other U.S.-listed quantum names also traded higher on Monday, with IonQ up about 4%, Rigetti Computing up 7.5% and Quantum Computing Inc up nearly 12%, amplifying the sense of a sector-wide momentum trade.

D-Wave markets “annealing” quantum computers, a design aimed at finding good solutions to complex optimization problems such as scheduling and routing, and also says it is pursuing gate-model systems. The company sells access through its Leap cloud platform, which lets customers run workloads without owning the hardware.

QBTS traded between $27.79 and $31.20 on Monday, underscoring the stock’s wide intraday swings. About 31 million shares had changed hands by mid-afternoon, according to market data.

But options flow can be noisy, and large trades can reflect hedges as much as directional conviction. If CES does not bring fresh commercial disclosures, the stock’s sharp moves can work in reverse, especially in a group where revenues remain small relative to valuations.

The next near-term test is D-Wave’s CES Foundry slate on Jan. 7–8. Traders are also looking ahead to the company’s Qubits 2026 conference on Jan. 27–28 for any roadmap updates and customer traction details.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Previous Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus
Next Story

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

Go toTop